Characterization of CMY-type β-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area

被引:27
作者
Decré, D
Verdet, C
Raskine, L
Blanchard, H
Burghoffer, B
Philippon, A
Sanson-Le-Pors, MJ
Petit, JC
Arlet, G
机构
[1] Hop St Antoine, Serv Bacteriol, UFR St Antoine, F-75012 Paris, France
[2] Hop Lariboisiere, Serv Bacteriol, F-75475 Paris, France
[3] CHU Cochin, Serv Bacteriol, AP HP, Paris, France
[4] Hop Tenon, Serv Bacteriol, UFR St Antoine, F-75970 Paris, France
关键词
D O I
10.1093/jac/dkf193
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We isolated five clinical strains (three Proteus mirabilis and two Klebsiella pneumoniae) with beta-lactam resistance phenotypes consistent with production of an AmpC-type beta-lactamase. The predicted amino acid sequences of the enzymes were typical of class C beta-lactamases. The enzymes were identified as CMY-2, CMY-4 and a new CMY-variant beta-lactamase, CMY-12. The AmpC beta-lactamases from the two K. pneumoniae isolates were found to be encoded on self-transferable plasmids. The genes encoding the AmpC-type beta-lactamase produced by the three P. mirabilis isolates were chromosomal. Four of the five clinical isolates were from patients transferred from Greece, Algeria and Egypt; one of the K. pneumoniae strains was recovered from a French patient. PFGE analysis and rep-PCR fingerprinting showed that the two P. mirabilis isolates from Greek patients were closely related.
引用
收藏
页码:681 / 688
页数:8
相关论文
共 39 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]  
ARLET G, 1995, FEMS MICROBIOL LETT, V134, P203, DOI 10.1111/j.1574-6968.1995.tb07938.x
[4]   Salmonella enteritidis:: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii [J].
Barnaud, G ;
Arlet, G ;
Verdet, C ;
Gaillot, O ;
Lagrange, PH ;
Philippon, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2352-2358
[5]   Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance [J].
Bauernfeind, A ;
Stemplinger, I ;
Jungwirth, R ;
Giamarellou, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :221-224
[6]   Plasmid-encoded AmpC β-lactamases:: How far have we gone 10 years after the discovery? [J].
Bauernfeind, A ;
Chong, Y ;
Lee, K .
YONSEI MEDICAL JOURNAL, 1998, 39 (06) :520-525
[7]   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[8]   Chromosomally encoded AmpC-type β-lactamase in a clinical isolate of Proteus mirabilis [J].
Bret, L ;
Chanal-Claris, C ;
Sirot, D ;
Chaibi, EB ;
Labia, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1110-1114
[9]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[10]   Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration [J].
Cao, VTB ;
Arlet, G ;
Ericsson, BM ;
Tammelin, A ;
Courvalin, P ;
Lambert, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :895-900